tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andy Chen, 24 are a BUY (75%), 1 are a SELL (3.13%), 7 are a HOLD (21.88%).
Analyst Andy Chen, currently employed at WOLFE, carries an average stock price target met ratio of 63.89% that have a potential upside of 39.75% achieved within 172 days.
Andy Chen’s has documented 56 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KYMR, Kymera Therapeutics at 10-Sep-2026.
Analyst best performing recommendations are on NTLA (INTELLIA THERAPEUTICS).
The best stock recommendation documented was for NTLA (INTELLIA THERAPEUTICS) at 9/24/2025. The price target of $25 was fulfilled within 15 days with a profit of $7.24 (40.77%) receiving and performance score of 27.18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Feb-2024
$50
$16.7 (50.15%)
$34
1 months 28 days ago
(04-Aug-2026)
4/7 (57.14%)
$10.64 (27.03%)
238
Buy Since 25-Apr-2023
$61
$27.7 (83.18%)
$58
3 months 2 days ago
(30-Jun-2026)
2/7 (28.57%)
$22.47 (58.32%)
100
Buy Since 23-May-2023
$62
$28.7 (86.19%)
$44
4 months 6 days ago
(26-May-2026)
8/13 (61.54%)
$28.17 (83.27%)
202
Hold Since 14-Oct-2025
$30
$-3.3 (-9.91%)
$23
4 months 10 days ago
(22-May-2026)
6/9 (66.67%)
$-4.15 (-12.15%)
294
Buy Since 29-Jul-2020
$40
$6.7 (20.12%)
$35
4 months 11 days ago
(21-May-2026)
16/25 (64%)
$5.87 (17.20%)
257
Which stock is Andy Chen most bullish on?
Which stock is Andy Chen most reserved on?
What Year was the first public recommendation made by Andy Chen?
